Literature DB >> 28365387

Structural analysis and insight into Zika virus NS5 mediated interferon inhibition.

Hamza Arshad Dar1, Tahreem Zaheer1, Rehan Zafar Paracha2, Amjad Ali3.   

Abstract

The Zika virus outbreak in 2015-2016 is the largest of its kind for which WHO declared a Public Health Emergency of International Concerns. No FDA approved drug is available for the treatment of the viral infection. The interaction of flavivirus NS5 protein with SIAH2 ubiquitin ligase has been previously known. NS5 of Zika virus has been implicated in the degradation of STAT2 protein, which activates interferon-stimulated antiviral activity. Based on our proposition that NS5 utilizes SIAH2-mediated proteasomal degradation of STAT2, an in-silico study was carried out to characterize the protein-protein interactions between NS5, SIAH2 and STAT2 proteins. The aim of our study was to identify the amino acid residues of NS5 involved in IFN antagonism as well as to find the association between NS5, SIAH2 and STAT2 to predict the interaction pattern of these proteins. Analysis proposed that NS5 recruits SIAH2 for the ubiquitination-dependent degradation of STAT2. NS5 residues involved in interaction with SIAH2 and/or STAT2 were found to be mostly conserved across related flaviviruses. These are novel findings regarding the Zika virus and require confirmation through experimental approaches.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Interferon antagonism; NS5 docking; Phylogenetic analysis; STAT2 degradation; Zika virus

Mesh:

Substances:

Year:  2017        PMID: 28365387     DOI: 10.1016/j.meegid.2017.03.027

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  8 in total

1.  Zika Virus Infection of Human Iris Pigment Epithelial Cells.

Authors:  Feargal J Ryan; Jillian M Carr; João M Furtado; Yuefang Ma; Liam M Ashander; Milena Simões; Genevieve F Oliver; G Bracho Granado; Abby C Dawson; Michael Z Michael; Binoy Appukuttan; David J Lynn; Justine R Smith
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

2.  Inter-organelle interactions between the ER and mitotic spindle facilitates Zika protease cleavage of human Kinesin-5 and results in mitotic defects.

Authors:  Liqiong Liu; Micquel Downs; Jesse Guidry; Edward J Wojcik
Journal:  iScience       Date:  2021-03-31

Review 3.  Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism.

Authors:  Yuchen Nan; Chunyan Wu; Yan-Jin Zhang
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

Review 4.  Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives.

Authors:  Ashok Munjal; Rekha Khandia; Kuldeep Dhama; Swati Sachan; Kumaragurubaran Karthik; Ruchi Tiwari; Yashpal S Malik; Deepak Kumar; Raj K Singh; Hafiz M N Iqbal; Sunil K Joshi
Journal:  Front Microbiol       Date:  2017-08-03       Impact factor: 5.640

Review 5.  The Molecular Basis of Viral Inhibition of IRF- and STAT-Dependent Immune Responses.

Authors:  Hao-Sen Chiang; Helene Minyi Liu
Journal:  Front Immunol       Date:  2019-01-08       Impact factor: 7.561

6.  New Targets for Zika Virus Determined by Human-Viral Interactomic: A Bioinformatics Approach.

Authors:  Eduardo Esteves; Nuno Rosa; Maria José Correia; Joel P Arrais; Marlene Barros
Journal:  Biomed Res Int       Date:  2017-12-12       Impact factor: 3.411

7.  Silent infection of human dendritic cells by African and Asian strains of Zika virus.

Authors:  Nathalie J Vielle; Beatrice Zumkehr; Obdulio García-Nicolás; Fabian Blank; Miloš Stojanov; Didier Musso; David Baud; Artur Summerfield; Marco P Alves
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

Review 8.  The A-Z of Zika drug discovery.

Authors:  Melina Mottin; Joyce V V B Borba; Rodolpho C Braga; Pedro H M Torres; Matheus C Martini; Jose Luiz Proenca-Modena; Carla C Judice; Fabio T M Costa; Sean Ekins; Alexander L Perryman; Carolina Horta Andrade
Journal:  Drug Discov Today       Date:  2018-06-20       Impact factor: 7.851

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.